Corsair Capital Management, L.P. Ikena Oncology, Inc. Transaction History
Corsair Capital Management, L.P.
- $404 Million
- Q3 2024
A detailed history of Corsair Capital Management, L.P. transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Corsair Capital Management, L.P. holds 24,830 shares of IKNA stock, worth $41,962. This represents 0.01% of its overall portfolio holdings.
Number of Shares
24,830
Previous 24,830
-0.0%
Holding current value
$41,962
Previous $40,000
5.0%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding IKNA
# of Institutions
62Shares Held
30.6MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$8.48 Million1.07% of portfolio
-
Bvf Inc San Francisco, CA4.77MShares$8.06 Million0.26% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$6.91 Million2.33% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$5.98 Million0.14% of portfolio
-
Omega Fund Management, LLC Boston, MA2.25MShares$3.8 Million5.77% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $61.3M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...